IR-Med Résultats passés

Passé contrôle des critères 0/6

IR-Med's earnings have been declining at an average annual rate of -30.4%, while the Medical Equipment industry saw earnings growing at 12.9% annually.

Informations clés

-30.4%

Taux de croissance des bénéfices

-21.0%

Taux de croissance du BPA

Medical Equipment Croissance de l'industrie	8.9%
Taux de croissance des recettes	n/a
Rendement des fonds propres	-956.7%
Marge nette	n/a
Dernière mise à jour des bénéfices	30 Jun 2024

Mises à jour récentes des performances passées

Pas de mise à jour

Recent updates

Ventilation des recettes et des dépenses

Comment IR-Med gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.

Historique des gains et des recettes

OTCPK:IRME Recettes, dépenses et bénéfices (USD Millions )
Date	Les revenus	Dépenses G+A	Dépenses de R&D
30 Jun 24	-3	2	1
31 Mar 24	-4	3	2
31 Dec 23	-5	3	2
30 Sep 23	-6	4	2
30 Jun 23	-5	3	2
31 Mar 23	-5	3	2
31 Dec 22	-5	3	2
30 Sep 22	-4	2	2
30 Jun 22	-4	2	2
31 Mar 22	-4	2	2
31 Dec 21	-4	2	1
30 Sep 21	-3	2	1
30 Jun 21	-2	2	1
31 Mar 21	-1	1	0
31 Dec 20	-1	0	0

Des revenus de qualité: IRME is currently unprofitable.

Augmentation de la marge bénéficiaire: IRME is currently unprofitable.

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Tendance des revenus: IRME is unprofitable, and losses have increased over the past 5 years at a rate of 30.4% per year.

Accélération de la croissance: Unable to compare IRME's earnings growth over the past year to its 5-year average as it is currently unprofitable

Bénéfices par rapport au secteur d'activité: IRME is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).

Rendement des fonds propres

ROE élevé: IRME has a negative Return on Equity (-956.75%), as it is currently unprofitable.

IR-Med Résultats passés

Passé contrôle des critères 0/6

Informations clés

Mises à jour récentes des performances passées

Recent updates

IR-Med Inc. Announces Chief Executive Officer Changes

IR-Med Inc. Receives $500,000 Grant from the Israel Innovation Authority to Develop its Platform Technology for the Early Detection of Diabetic Foot Ulcers

IR-Med Inc. has filed an IPO in the amount of $8 million.

IR-Med Inc. Appoints Avital Rosenberg as A Class I Director and Member of the Audit Committee

IR-Med Inc.’s PressureSafe Reduced Pressure Injuries by 50% During a Usability Study with Clalit, Israel’s Hmo

IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries

IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16

IR-Med Inc., Annual General Meeting, Nov 07, 2023

IR-MED Announces Executive Changes Effective as of October 15, 2023

Ir-Med to Conduct Usability Study with Methodist Healthcare of San Antonio for Its Pressuresafe Device Which Is Slated for U.S. Launch in H1 2024

IR-Med Inc. Appoints Richard Serbin, Esq. to Its Advisory Board

Ir-Med Inc. Announces Interim Results from A Clinical Study of Pressuresafe

IR-Med Inc. Appoints Lynn Eschenbacher to its Advisory Board

IR-Med Inc., Annual General Meeting, Dec 12, 2022

IR-Med Announces Appointment of Moshe Gerber as Chief Executive Officer

International Display Advertising, Inc. (OTCPK:IDAD.D) completed the acquisition of IR Med, Ltd.

International Display Advertising, Inc. announced that it expects to receive $5 million in funding

Ventilation des recettes et des dépenses

Historique des gains et des recettes

Analyse des flux de trésorerie disponibles par rapport aux bénéfices

Analyse de la croissance passée des bénéfices

Rendement des fonds propres

Rendement des actifs

Rendement des capitaux employés

Découvrir des entreprises performantes dans le passé